Peter Dans brings over 25 years of diverse finance experience to Synaptive. For four years, Peter was CFO of Nordion Inc., a health sciences company that was listed on the TSX and NYSE prior to its sale to Sterigenics. Peter has also held CFO roles at Therapure Biopharma and LG-Nortel, and has lived and worked in the Philippines, Singapore and Korea. Peter holds a MBA and both CPA and P. Eng. designations.